Cargando…

Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer cases

OBJECTIVES: To compare results of selected performance measures in mammographic screening for an artificial intelligence (AI) system versus independent double reading by radiologists. METHODS: In this retrospective study, we analyzed data from 949 screen-detected breast cancers, 305 interval cancers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koch, Henrik Wethe, Larsen, Marthe, Bartsch, Hauke, Kurz, Kathinka Dæhli, Hofvind, Solveig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Breast
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121532/ https://www.ncbi.nlm.nih.gov/pubmed/36917260 http://dx.doi.org/10.1007/s00330-023-09461-y

Ejemplares similares

Personalized Breast Cancer Screening: A Risk Prediction Model Based on Women Attending BreastScreen Norway
por: Louro, Javier, et al.
Publicado: (2023)

Early screening outcomes among non-immigrants and immigrants targeted by BreastScreen Norway, 2010–2019
por: Thy, Jonas E., et al.
Publicado: (2022)

Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading
por: Martiniussen, Marit A., et al.
Publicado: (2022)

Effect of invitation letter in language of origin on screening attendance: randomised controlled trial in BreastScreen Norway
por: Hofvind, Solveig, et al.
Publicado: (2023)

Radiological review of prior screening mammograms of screen-detected breast cancer
por: Hovda, Tone, et al.
Publicado: (2020)

Does it matter for the radiologists’ performance whether they read short or long batches in organized mammographic screening?
por: Backmann, Heinrich A., et al.
Publicado: (2021)

Possible strategies for use of artificial intelligence in screen-reading of mammograms, based on retrospective data from 122,969 screening examinations
por: Larsen, Marthe, et al.
Publicado: (2022)

Cross-national comparison of screening mammography accuracy measures in U.S., Norway, and Spain
por: Domingo, Laia, et al.
Publicado: (2015)

Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review
por: Tsuruda, Kaitlyn M., et al.
Publicado: (2020)

Can artificial intelligence reduce the interval cancer rate in mammography screening?
por: Lång, Kristina, et al.
Publicado: (2021)

A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial
por: Aase, Hildegunn S., et al.
Publicado: (2018)

Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway
por: Moshina, Nataliia, et al.
Publicado: (2021)

Artifacts on Magnetic Resonance Imaging from Electronic Identification Enablement in Silicone Gel Implants Are Not Negligible
por: Kurz, Kathinka D., et al.
Publicado: (2021)

Effect of invitation letter in language of origin on screening attendance: randomised controlled trial in BreastScreen Norway
Publicado: (2023)

Economic potential of abbreviated breast MRI for screening women with dense breast tissue for breast cancer
por: Tollens, Fabian, et al.
Publicado: (2022)

Breast Implant-associated Anaplastic Large Cell Lymphoma after Breast Reconstruction for Breast Cancer
por: Mesa, Felipe, et al.
Publicado: (2023)

Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer
por: Minarikova, Lenka, et al.
Publicado: (2016)

The COVID‐19 BreastScreen Department – beyond the pandemic
por: Spuur, Kelly Maree
Publicado: (2020)

Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)
por: Mann, Ritse M., et al.
Publicado: (2022)

Breast Reconstruction in Inflammatory Breast Cancer: An Analysis of Predictors, Trends, and Survival from the National Cancer Database
por: Karadsheh, Murad J., et al.
Publicado: (2021)

Autologous Breast Reconstruction after Mastectomy for Breast Cancer: A Systematic Review
por: Saldanha, Ian J., et al.
Publicado: (2022)

The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program
por: Wang, Jing, et al.
Publicado: (2020)

Breast density and the likelihood of malignant MRI-detected lesions in women diagnosed with breast cancer
por: Sassi, Antti, et al.
Publicado: (2023)

Psychological and Aesthetic Outcomes in Breast Cancer Patients
por: Ermoshchenkova, Maria V., et al.
Publicado: (2021)

Breast cancer detection: radiologists’ performance using mammography with and without automated whole-breast ultrasound
por: Kelly, Kevin M., et al.
Publicado: (2010)

Pleuroperitoneal (Denver) Shunt for Recurrent Nonmalignant Breast Seroma in a Metastatic Breast Cancer Patient
por: Pflibsen, Lacey R., et al.
Publicado: (2020)

Evaluation of reader performance during interpretation of breast cancer screening: the Recall and detection Of breast Cancer in Screening (ROCS) trial study design
por: Sechopoulos, Ioannis, et al.
Publicado: (2022)

Endoscopic-assisted Nipple-sparing Mastectomy with Direct-to-Implant Subpectoral Breast Reconstruction in the Management of Breast Cancer
por: Zhang, Songbo, et al.
Publicado: (2021)

Implant-based Breast Reconstruction after Mastectomy for Breast Cancer: A Systematic Review and Meta-analysis
por: Saldanha, Ian J., et al.
Publicado: (2022)

Breast cancer screening with digital breast tomosynthesis: comparison of different reading strategies implementing artificial intelligence
por: Dahlblom, Victor, et al.
Publicado: (2022)

Evidence Mapping of the Treatments for Breast Cancer–related Lymphedema
por: Al-Sakkaf, Ali M., et al.
Publicado: (2022)

Quality management: the key to achievement for the BreastScreen Australia Programme
por: Muller, J
Publicado: (2004)

Artificial intelligence (AI) for breast cancer screening: BreastScreen population-based cohort study of cancer detection
por: Marinovich, M. Luke, et al.
Publicado: (2023)

Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey
por: Sardanelli, Francesco, et al.
Publicado: (2016)

Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review
por: Robertson, Clare, et al.
Publicado: (2011)

Prospective trial comparing full-field digital mammography (FFDM) versus combined FFDM and tomosynthesis in a population-based screening programme using independent double reading with arbitration
por: Skaane, Per, et al.
Publicado: (2013)

Neighborhood socioeconomic status and low‐value breast cancer care
por: Chen, J. C., et al.
Publicado: (2022)

False positives in breast cancer screening with one-view breast tomosynthesis: An analysis of findings leading to recall, work-up and biopsy rates in the Malmö Breast Tomosynthesis Screening Trial
por: Lång, Kristina, et al.
Publicado: (2016)

One-view digital breast tomosynthesis as a stand-alone modality for breast cancer detection: do we need more?
por: Rodriguez-Ruiz, Alejandro, et al.
Publicado: (2017)

Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer
por: Samiei, Sanaz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ed8hicneskb9rnfkm6u3b58cod